FDA approves AstraZeneca’s Calquence for untreated mantle cell lymphoma By Investing.com
Investing.com -- AstraZeneca (LON:) in a inventory alternate submitting on Friday stated that the FDA accredited its drug Calquence (acalabrutinib) ...
Investing.com -- AstraZeneca (LON:) in a inventory alternate submitting on Friday stated that the FDA accredited its drug Calquence (acalabrutinib) ...
Investing.com-- U.S. President-elect Donald Trump is making ready to signal an govt order making cryptocurrency a nationwide coverage precedence and granting ...
Investing.com-- Insignia Monetary Ltd (ASX:) stated on Thursday it obtained a sweetened takeover bid from U.S.-based non-public fairness agency CC ...
Investing.com – Norway shares have been decrease after the shut on Thursday, as losses within the , and sectors led ...
Investing.com-- Brazilian airline Azul SA (NYSE:) and Abra- the bulk investor in its rival Gol, mentioned they'd signed a non-binding ...
Pre-winter readiness actions accomplished by the corporate in December; crews performing readiness checklists for electrical and methodsProspects urged to have ...
Investing.com -- Shares of Shoals Applied sciences Group skilled a document intraday drop of as a lot as 23% following ...
Investing.com-- Bitcoin prolonged beneficial properties on Wednesday after a pointy rebound within the earlier periods amid a bullish outlook for ...
Investing.com -- Shares of pharmaceutical firm Eli Lilly & Co (NYSE:) skilled a major drop, as a lot as 8.6%, ...
Investing.com -- Google, owned by Alphabet (NASDAQ:), is below investigation by United Kingdom (TADAWUL:) antitrust officers over its search companies ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.